Advanced Ultrasound in Diagnosis and Therapy ›› 2026, Vol. 10 ›› Issue (4): 233-244.doi: 10.26599/AUDT.2026.260034
• ORIGINAL RESEARCH • Next Articles
Yang Shenglana, Luo Xiaoyua, Zheng Wendia, Yue Xiaoyua, Liu Wenhaoa, Pan Yanana, Zhou Yichuna, Wan Xiaoyua, Xu Mingjuna, Zhang Meia,*(
)
Received:2026-08-30
Revised:2026-09-16
Accepted:2026-10-11
Online:2026-12-30
Published:2026-11-02
Contact:
Zhang Mei,
E-mail:daixh@vip.sina.com
Yang Shenglan, Luo Xiaoyu, Zheng Wendi, Yue Xiaoyu, Liu Wenhao, Pan Yanan, Zhou Yichun, Wan Xiaoyu, Xu Mingjun, Zhang Mei. High Resolution Ultrasound Radiomics Differences in Carotid Plaques between Patients with and without Ischemic Stroke. Advanced Ultrasound in Diagnosis and Therapy, 2026, 10(4): 233-244.
Table 1
Clinical characteristics of patients without IS, patients with IS in the primary cohort, and patients in the additional IS cohort"
| Characteristic | Without IS (n = 787) | Primary IS (n = 361) | Additional IS (n = 83) | P value 1 | P value 2 |
| Values are presented as mean (SD), median (25th to 75th percentile), or n (%). P value 1 compares patients without IS with patients with IS in the primary cohort; P value 2 compares patients with IS in the primary cohort with those in the additional IS cohort. ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; Cr, creatinine; DBP, diastolic blood pressure; FBG, fasting blood glucose; HDL-C, high-density lipoprotein cholesterol; IS, ischemic stroke; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride | |||||
| Age, years | 70.0 (65.0-74.0) | 68.0 (61.0-72.0) | 68.0 (64.0-71.0) | < 0.001 | 0.893 |
| Height, m | 1.62 (0.09) | 1.65 (0.08) | 1.66 (0.08) | < 0.001 | 0.856 |
| Weight, kg | 66.8 (11.1) | 69.0 (11.0) | 66.6 (10.5) | 0.002 | 0.065 |
| BMI, kg/m2 | 25.4 (3.4) | 25.2 (3.4) | 24.2 (3.3) | 0.381 | 0.023 |
| SBP, mmHg | 134.2 (19.0) | 139.4 (20.2) | 141.7 (19.5) | < 0.001 | 0.332 |
| DBP, mmHg | 73.9 (10.9) | 77.9 (13.1) | 80.2 (10.0) | < 0.001 | 0.079 |
| ALT, U/L | 16.0 (12.0-23.0) | 18.0 (13.0-27.0) | 20.0 (16.0-30.0) | 0.010 | 0.024 |
| AST, U/L | 20.9 (17.1-25.0) | 18.0 (15.0-23.0) | 21.0 (18.0-25.0) | < 0.001 | 0.001 |
| TC, mmol/L | 4.50 (3.44-5.41) | 3.63 (3.06-4.48) | 3.44 (2.93-3.97) | < 0.001 | 0.021 |
| HDL-C, mmol/L | 1.20 (1.00-1.43) | 1.08 (0.91-1.29) | 1.16 (0.96-1.26) | < 0.001 | 0.598 |
| LDL-C, mmol/L | 2.50 (1.83-3.18) | 1.99 (1.63-2.60) | 1.79 (1.53-2.41) | < 0.001 | 0.060 |
| TG, mmol/L | 1.30 (0.96-1.79) | 1.20 (0.91-1.65) | 1.11 (0.78-1.43) | 0.055 | 0.058 |
| Cr, umol/L | 70.5 (60.4-80.0) | 70.0 (60.0-80.0) | 68.0 (60.0–80.5) | 0.305 | 0.928 |
| FBG, mmol/L | 5.80 (5.20-6.70) | 5.71 (4.92-6.96) | 5.16 (4.58-5.73) | 0.332 | < 0.001 |
| Male sex | 446 (56.7%) | 236 (65.4%) | 62 (74.7%) | 0.005 | 0.103 |
| Hypertension | 405 (51.5%) | 251 (69.5%) | 49 (59.0%) | < 0.001 | 0.066 |
| Diabetes mellitus | 225 (28.6%) | 140 (38.8%) | 24 (28.9%) | < 0.001 | 0.043 |
| Coronary heart disease | 359 (45.6%) | 121 (33.5%) | 14 (16.9%) | < 0.001 | 0.003 |
| Lipid-lowering medication | 264 (33.5%) | 208 (57.6%) | 22 (26.8%) | < 0.001 | < 0.001 |
| Current or former smoking | 278 (35.3%) | 135 (37.4%) | 44 (53.0%) | 0.497 | 0.009 |
| Alcohol consumption | 246 (31.3%) | 118 (32.7%) | 51 (61.4%) | 0.629 | < 0.001 |
Table 2
Overlap-weighting balance diagnostics for the eight clinical covariates in the primary cohort"
| Characteristic | Unweighted SMD | Weighted SMD | Weighted without IS | Weighted with IS |
| Weighted values are presented as mean age in years or percentages for categorical variables. IS, ischemic stroke; SMD, standardized mean difference | ||||
| Age, years | −0.229 | −0.001 | 67.71 | 67.71 |
| Male sex | 0.179 | 0.001 | 62.68 | 62.74 |
| Hypertension | 0.376 | 0.002 | 65.20 | 65.30 |
| Diabetes mellitus | 0.217 | < 0.001 | 36.45 | 36.49 |
| Coronary heart disease | −0.249 | −0.005 | 42.63 | 42.40 |
| Current or former smoking | 0.043 | < 0.001 | 37.87 | 37.86 |
| Alcohol consumption | 0.031 | < 0.001 | 32.14 | 32.12 |
| Lipid-lowering medication | 0.498 | 0.004 | 45.66 | 45.88 |
Table 3
Radiomics features meeting the prespecified reliability and robustness criteria"
| Feature | Weighted OR (95% CI) | FDR q | Selection, % | Direction, % | ICC |
| ORs are per one standard deviation of each feature. Selection is the percentage of 1,000 bootstrap samples in which the feature was selected; direction is coefficient sign consistency among selected samples. ICC is the lower of the intraobserver and interobserver ICCs. q values are false discovery rate–adjusted P values. CI, confidence interval; FDR, false discovery rate; ICC, intraclass correlation coefficient; OR, odds ratio. | |||||
| wavelet-LH_glcm_InverseVariance | 1.35 (1.10-1.64) | 0.026 | 93.5 | 96.8 | 0.938 |
| original_firstorder_10Percentile | 0.71 (0.58-0.88) | 0.016 | 90.3 | 95.8 | 0.931 |
| wavelet-HL_glcm_MaximumProbability | 1.50 (1.13-1.97) | 0.029 | 90.1 | 98.4 | 0.903 |
| wavelet-LH_glrlm_RunEntropy | 0.60 (0.49-0.74) | < 0.001 | 85.1 | 99.8 | 0.897 |
| wavelet-LH_glszm_SizeZoneNonUniformityNormalized | 1.37 (1.09-1.72) | 0.039 | 77.7 | 100.0 | 0.972 |
| wavelet-HH_glszm_GrayLevelNonUniformityNormalized | 0.74 (0.60-0.90) | 0.027 | 77.4 | 88.8 | 0.914 |
| wavelet-HL_glszm_SizeZoneNonUniformityNormalized | 1.38 (1.10-1.71) | 0.029 | 77.2 | 94.3 | 0.877 |
Table 4
Full pipeline bootstrap internal validation with 1,000 iterations"
| Metric | Apparent | Optimism-corrected | Mean optimism | Optimism 95% interval |
| AUC | 0.776 | 0.724 | 0.051 | 0.017 to 0.085 |
| Brier score | 0.164 | 0.182 | −0.019 | −0.037 to −0.003 |
| Calibration intercept | −0.023 | −0.017 | −0.006 | −0.156 to 0.142 |
| Calibration slope | 1.213 | 0.905 | 0.307 | 0.118 to 0.483 |
Table 5
Robust features in the primary and expanded clinical models"
| Radiomics feature | Primary OR (95% CI) | Primary q | Expanded OR (95% CI) | Expanded q |
| Odds ratios are per one-standard-deviation increase in the radiomics feature. CI, confidence interval; OR, odds ratio | ||||
| wavelet-LH_glcm_InverseVariance | 1.35 (1.10-1.64) | 0.026 | 1.31 (1.07-1.61) | 0.075 |
| original_firstorder_10Percentile | 0.71 (0.58-0.88) | 0.016 | 0.72 (0.58-0.90) | 0.054 |
| wavelet-HL_glcm_MaximumProbability | 1.50 (1.13-1.97) | 0.029 | 1.48 (1.11-1.96) | 0.060 |
| wavelet-LH_glrlm_RunEntropy | 0.60 (0.49-0.74) | < 0.001 | 0.64 (0.52-0.79) | 0.013 |
| wavelet-LH_glszm_SizeZoneNonUniformityNormalized | 1.37 (1.09-1.72) | 0.039 | 1.25 (1.00-1.55) | 0.204 |
| wavelet-HH_glszm_GrayLevelNonUniformityNormalized | 0.74 (0.60-0.90) | 0.027 | 0.81 (0.66-0.99) | 0.189 |
| wavelet-HL_glszm_SizeZoneNonUniformityNormalized | 1.38 (1.10-1.71) | 0.029 | 1.24 (1.00-1.55) | 0.203 |
| [1] |
GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurology 2021; 20: 795-820.
doi: 10.1016/S1474-4422(21)00252-0 |
| [2] |
Naylor AR, Rantner B, Ancetti S. European society for vascular surgery 2023 clinical practice guidelines on the management of atherosclerotic carotid and vertebral artery disease. European Journal of Vascular and Endovascular Surgery 2023; 65: 7-111.
doi: 10.1016/j.ejvs.2022.04.011 |
| [3] |
Saba L, Brinjikji W, Spence JD, Wintermark M, Castillo M, Borst GJD de, et al. Roadmap consensus on carotid artery plaque imaging and impact on therapy strategies and guidelines: an international, multispecialty, expert review and position statement. AJNR Am J Neuroradiol 2021; 42: 1566-1575.
doi: 10.3174/ajnr.A7223 |
| [4] |
Zwanenburg A, Vallieres M, Abdalah MA. The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology 2020; 295: 328-338.
doi: 10.1148/radiol.2020191145 |
| [5] |
Griethuysen JJM van, Fedorov A, Parmar C. Computational radiomics system to decode the radiographic phenotype. Cancer Research 2017; 77: e104-e107.
doi: 10.1158/0008-5472.CAN-17-0339 |
| [6] |
Huang Z, Cheng X-Q, Liu H-Y, Bi X-J, Liu Y-N, Lv W-Z, et al. Relation of carotid plaque features detected with ultrasonography-based radiomics to clinical symptoms. Translational Stroke Research 2022; 13: 970-982.
doi: 10.1007/s12975-021-00963-9 |
| [7] |
Song J, Zou L, Li Y, Wang X, Qiu J, Gong K. Combining artificial intelligence assisted image segmentation and ultrasound based radiomics for the prediction of carotid plaque stability. BMC Medical Imaging 2025; 25: 89.
doi: 10.1186/s12880-025-01621-4 |
| [8] |
Chen S, Liu C, Chen X, Liu WV, Ma L, Zha Y. A radiomics approach to assess high risk carotid plaques: a non invasive imaging biomarker, retrospective study. Frontiers in Neurology 2022; 13: 788652.
doi: 10.3389/fneur.2022.788652 |
| [9] |
Shi J, Sun Y, Hou J. Radiomics signatures of carotid plaque on computed tomography angiography: an approach to identify symptomatic plaques. Clinical Neuroradiology 2023; 33: 931-941.
doi: 10.1007/s00062-023-01289-9 |
| [10] |
Mohler ER 3rd, Sibley AA, Schultz SM, Zhang L, Sehgal CM. High-frequency ultrasound for evaluation of intimal thickness. J Am Soc Echocardiogr 2009; 22: 1129-1133.
doi: 10.1016/j.echo.2009.06.021 |
| [11] |
Xu M, Jin S, Li F, Jia G, Zhang C, Zhang M, et al. The diagnostic value of radial and carotid intima thickness measured by high-resolution ultrasound for ischemic stroke. Journal of the American Society of Echocardiography 2021; 34: 72-82.
doi: 10.1016/j.echo.2020.09.006 |
| [12] |
Vacca S, Scicolone R, Gupta A. Atherosclerotic carotid artery disease radiomics: a systematic review with meta-analysis and radiomic quality score assessment. European Journal of Radiology 2024; 177: 111547.
doi: 10.1016/j.ejrad.2024.111547 |
| [13] |
Hou C, Liu XY, Du Y. Radiomics in carotid plaque: a systematic review and Radiomics Quality Score assessment. Ultrasound in Medicine and Biology 2023; 49: 2437-2445.
doi: 10.1016/j.ultrasmedbio.2023.06.008 |
| [14] |
Pfaehler E, Zwanenburg A, Jong JR de, Boellaard R. Repeatability and reproducibility of radiomic features: a systematic review. Radiotherapy and Oncology 2019; 133: 176-187.
doi: 10.1016/j.radonc.2019.01.034 |
| [15] |
Teng X, Wang Y, Nicol AJ. Enhancing the clinical utility of radiomics: addressing the challenges of repeatability and reproducibility in CT and MRI. Diagnostics 2024; 14: 1835.
doi: 10.3390/diagnostics14161835 |
| [16] |
Wang X, Pennello G, deSouza NM. Multiparametric data-driven imaging markers: guidelines for development, application and reporting of model outputs in radiomics. Academic Radiology 2023; 30: 215-229.
doi: 10.1016/j.acra.2022.10.001 |
| [17] |
An C, Park YW, Ahn SS, Han K, Kim H, Lee S-K. Radiomics machine learning study with a small sample size: Single random training-test set split may lead to unreliable results. PLoS One 2021; 16: e0256152.
doi: 10.1371/journal.pone.0256152 |
| [18] |
Johri AM, Nambi V, Naqvi TZ. Recommendations for the assessment of carotid arterial plaque by ultrasound for the characterization of atherosclerosis and evaluation of cardiovascular risk. Journal of the American Society of Echocardiography 2020; 33: 917-933.
doi: 10.1016/j.echo.2020.04.021 |
| [19] |
Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. Journal of Chiropractic Medicine 2016; 15: 155-163.
doi: 10.1016/j.jcm.2016.02.012 |
| [20] |
Li F, Morgan KL, Zaslavsky AM. Balancing covariates via propensity score weighting. Journal of the American Statistical Association 2018; 113: 390-400.
doi: 10.1080/01621459.2016.1260466 |
| [21] |
Meinshausen N, Buhlmann P. Stability selection. Journal of the Royal Statistical Society Series B 2010; 72: 417-473.
doi: 10.1111/j.1467-9868.2010.00740.x |
| [22] |
Chen C, Tang W, Chen Y, Xu W, Yu N, Liu C. Computed tomography angiography based radiomics model to identify high risk carotid plaques. Quantitative Imaging in Medicine and Surgery 2023; 13: 6089-6104.
doi: 10.21037/qims-23-158 |
| [23] |
Kleindorfer DO, Towfighi A, Chaturvedi S. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke 2021; 52: e364-e467.
doi: 10.1161/str.0000000000000383 |
| [1] | Cao Jiaying, Li Wenying, Qiu Yijie, Wei Li, Wang Ying, Huang Yunlin, Dong Yi, Dietrich Christoph F. Decoding Hepatocellular Carcinoma Heterogeneity with Multimodal Ultrasound and Acoustic Radiomics [J]. Advanced Ultrasound in Diagnosis and Therapy, 2026, 10(4): 334-345. |
| [2] | Li Mo, Jin Letian, Xue Ge, Chen Jiye, Benariba Mohamed Aimene, Wang Vicky Yang, Teng Gaojun, Xu Dong. Empowering Breast Cancer Precision Diagnosis with Advanced Ultrasound: From Radiomics to Radio-multiomics [J]. Advanced Ultrasound in Diagnosis and Therapy, 2026, 10(4): 277-297. |
| [3] | Gao Yuanjing, Niu Zihan, Luo Yanwen, Zhou Mengyuan, Xiao Mengsu, Jiang Yuxin, Zhu Qingli. Research Progress on Ultrasound Radiomics in Preoperative Prediction of Axillary Lymph Node Metastasis in Breast Cancer [J]. Advanced Ultrasound in Diagnosis and Therapy, 2026, 10(2): 79-89. |
| [4] | Zhang Xiaoqian, Zhang Jingwen, Dong Yijie, Zhou Jianqiao. Research Progress and Clinical Translation of Photoacoustic–ultrasound Fusion Imaging in Breast Cancer Diagnosis and Therapy [J]. Advanced Ultrasound in Diagnosis and Therapy, 2025, 9(4): 467-482. |
| [5] | Zhong Xian, Xie Xiaoyan. Multimodal Ultrasound Radiomics in Liver Disease: Current Status and Future Directions [J]. Advanced Ultrasound in Diagnosis and Therapy, 2025, 9(4): 388-408. |
| [6] | Cui Liuping, Liu Ran, Liu Yumei, Zhou Fubo, Tao Yunlu, Xing Yingqi. Reviews on Imaging-based Risk Prediction Models for Ischemic Stroke [J]. Advanced Ultrasound in Diagnosis and Therapy, 2025, 9(2): 117-126. |
| [7] | Wenjun Zhang, MD, Mi Zhou, PhD, Qingguo Meng, MD, Lin Zhang, MS, Xin Liu, MS, Paul Liu, PhD, Dong Liu, PhD. Rapid Screening of Carotid Plaque in Cloud Handheld Ultrasound System Based on 5G and AI Technology [J]. Advanced Ultrasound in Diagnosis and Therapy, 2023, 7(2): 152-157. |
| [8] | Yi Chen, MB, Xia Liu, MB, Run Wang, MD, Xiaona Lin, MM, Jieyu Zhong, MD, Yan Chen, MM, Huali Cai, MB, Yongbin Li, MM, Zhicheng Li, MD, Zhengming Hu, MD, Desheng Sun, MD. Ultrasound Radiomics in Breast Cancer - A Literature Review [J]. Advanced Ultrasound in Diagnosis and Therapy, 2021, 5(1): 12-17. |
| [9] | Bing Mao, MD, Shaobo Duan, MD, Ruiqing Liu, MD, Na Li, PhD, Yaqiong Li, PhD, Lianzhong Zhang, MD. The Roles of Ultrasound-Based Radiomics In Precision Diagnosis and Treatment of Different Cancers: A Literature Review [J]. Advanced Ultrasound in Diagnosis and Therapy, 2020, 4(4): 291-296. |
| [10] | Yumei Liu, MD, Beibei Liu, MD, MS, Boyu Li, MD, PhD, Yang Hua, MD. Coronary Heart Disease Concomitant with Atherosclerotic Cerebrovascular Disease [J]. Advanced Ultrasound in Diagnosis and Therapy, 2019, 3(3): 76-80. |
| [11] | Sriharsha Gummadi, MD, John Eisenbrey, PhD, Jingzhi Li, MD, Zhaojun Li, MD, Flemming Forsberg, PhD, Andrej Lyshchik, MD, Ji-Bin Liu, MD. Advances in Modern Clinical Ultrasound [J]. Advanced Ultrasound in Diagnosis and Therapy, 2018, 2(2): 51-63. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
Share: WeChat
Copyright ©2018 Advanced Ultrasound in Diagnosis and Therapy
|
Advanced Ultrasound in Diagnosis and Therapy (AUDT) a>
is licensed under a Creative Commons Attribution 4.0 International License a>.
